These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

296 related items for PubMed ID: 29055248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.
    Schellings MW, Boonen K, Schmitz EM, Jonkers F, van den Heuvel DJ, Besselaar A, Hendriks JG, van de Kerkhof D.
    Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Development and validation of an ultra-high performance liquid chromatography with tandem mass spectrometry method for the simultaneous quantification of direct oral anticoagulants in human plasma.
    Zhang YF, Liu XQ, Wang Y, Xu X, Zhong MK, Zhang P, Ma CL.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Oct 01; 1182():122952. PubMed ID: 34598085
    [Abstract] [Full Text] [Related]

  • 5. Development, validation and application of a new HPLC-DAD method for simultaneous quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma.
    Gouveia F, Bicker J, Santos J, Rocha M, Alves G, Falcão A, Fortuna A.
    J Pharm Biomed Anal; 2020 Mar 20; 181():113109. PubMed ID: 31981828
    [Abstract] [Full Text] [Related]

  • 6. Dried-Blood-Spot Technique to Monitor Direct Oral Anticoagulants: Clinical Validation of a UPLC-MS/MS-Based Assay.
    Foerster KI, Huppertz A, Meid AD, Müller OJ, Rizos T, Tilemann L, Haefeli WE, Burhenne J.
    Anal Chem; 2018 Aug 07; 90(15):9395-9402. PubMed ID: 29985592
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma.
    Baldelli S, Cattaneo D, Pignatelli P, Perrone V, Pastori D, Radice S, Violi F, Clementi E.
    Bioanalysis; 2016 Feb 07; 8(4):275-83. PubMed ID: 26808218
    [Abstract] [Full Text] [Related]

  • 9. Quantitation of the Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Warfarin in Plasma Using Ultra-Performance Liquid Chromatography with Tandem Mass Spectrometry (UPLC-MS/MS).
    Noguez JH, Ritchie JC.
    Methods Mol Biol; 2016 Feb 07; 1383():21-7. PubMed ID: 26660170
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Generic Methods for Simultaneous Analysis of Four Direct Oral Anticoagulants in Human Plasma and Urine by Ultra-High Performance Liquid Chromatography-Tandem Mass Spectrometry.
    Ren JW, Zheng X, Han XH.
    Molecules; 2023 Feb 28; 28(5):. PubMed ID: 36903499
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Quantification of Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in Human Serum by UHPLC-MS/MS-Method Development, Validation, and Application.
    Lindahl S, Dyrkorn R, Spigset O, Hegstad S.
    Ther Drug Monit; 2018 Jun 28; 40(3):369-376. PubMed ID: 29578938
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays.
    Kuhn J, Gripp T, Flieder T, Hammerschmidt A, Hendig D, Faust I, Knabbe C, Birschmann I.
    Clin Chim Acta; 2018 Nov 28; 486():347-356. PubMed ID: 30114406
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of the effect of the anti-Xa direct oral anticoagulants apixaban, edoxaban, and rivaroxaban on coagulation assays.
    Gosselin R, Grant RP, Adcock DM.
    Int J Lab Hematol; 2016 Oct 28; 38(5):505-13. PubMed ID: 27265752
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.